Fulgent Genetics Correlations
FLGT Stock | USD 17.33 0.28 1.64% |
The current 90-days correlation between Fulgent Genetics and Caredx Inc is -0.22 (i.e., Very good diversification). The correlation of Fulgent Genetics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Fulgent |
Moving together with Fulgent Stock
Moving against Fulgent Stock
0.67 | ABT | Abbott Laboratories Earnings Call This Week | PairCorr |
0.53 | MD | Mednax Inc | PairCorr |
0.51 | DOCS | Doximity | PairCorr |
0.48 | GH | Guardant Health | PairCorr |
0.48 | LH | Laboratory | PairCorr |
0.39 | FEMY | Femasys | PairCorr |
0.32 | EHAB | Enhabit | PairCorr |
0.62 | BSX | Boston Scientific Corp | PairCorr |
0.59 | EHC | Encompass Health Corp | PairCorr |
0.58 | CON | Concentra Group Holdings | PairCorr |
0.56 | ALC | Alcon AG | PairCorr |
0.54 | DGX | Quest Diagnostics | PairCorr |
0.44 | CVS | CVS Health Corp | PairCorr |
0.34 | BVS | Bioventus | PairCorr |
0.32 | CAH | Cardinal Health | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Fulgent Stock performing well and Fulgent Genetics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Fulgent Genetics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ILMN | 2.19 | (0.76) | 0.00 | (0.81) | 0.00 | 3.40 | 15.07 | |||
TTOO | 8.95 | (0.46) | 0.00 | 0.04 | 0.00 | 17.14 | 130.00 | |||
A | 1.41 | (0.44) | 0.00 | 5.05 | 0.00 | 2.92 | 9.62 | |||
MTD | 1.51 | (0.34) | 0.00 | 2.19 | 0.00 | 2.34 | 11.27 | |||
WAT | 1.65 | (0.27) | 0.00 | 1.18 | 0.00 | 2.95 | 10.99 | |||
DHR | 1.38 | (0.41) | 0.00 | 4.82 | 0.00 | 2.26 | 12.14 | |||
TMO | 1.40 | (0.16) | 0.00 | (0.24) | 0.00 | 2.44 | 13.61 | |||
CRL | 1.97 | (0.60) | 0.00 | 1.26 | 0.00 | 3.86 | 12.43 | |||
CDNA | 3.27 | (0.05) | 0.00 | (0.11) | 0.00 | 6.09 | 19.59 |
Fulgent Genetics Corporate Management
Doreen Ng | Vice Compliance | Profile | |
DABMG FACMG | Chief Director | Profile | |
Paul Kim | Chief Officer | Profile | |
Natalie Prescott | General Officer | Profile | |
Lawrence MD | Chief Officer | Profile |